| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Trager James is a Chief Scientific Officer at NKTX. Recent filings cover 0 purchases and 12 sales. Those positions are worth an estimated $352K at current prices.
Our model assigns Trager James a strong insider score of 74/100, based on 8 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +41.9%.
Trager James's largest disclosed position is in NKTX as Chief Scientific Officer, worth about $352K. The recent filings there lean toward selling, a net 29,313 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sell | 456 | $5.60 | $2,553.60 | -0.3% | +7.2% | -65.5% | |
| Feb 12, 2024 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sell | 4,143 | $12.00 | $49,716.00 | -2.7% | -41.8% | -82.1% | |
| Jan 16, 2024 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sell | 4,560 | $8.74 | $39,854.40 | -2.9% | +0.5% | -74.2% | |
| Jun 20, 2023 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sell | 439 | $4.85 | $2,129.15 | -0.4% | -67.1% | +8.7% | |
| Jan 17, 2023 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sell | 1,115 | $5.49 | $6,121.35 | -1.1% | -14.2% | +67.2% | |
| Aug 15, 2022 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sale+OE | 5,000 | $17.53 | $87,655.50 | -7.4% | -38.6% | -89.2% | |
| Aug 2, 2021 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sale+OE | 3,600 | $31.53 | $113,508.00 | -7.5% | -47.8% | -60.7% | |
| May 3, 2021 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sale+OE | 3,600 | $31.64 | $113,904.00 | -3.8% | +5.9% | -39.2% | |
| Feb 2, 2021 | NKTX Nkarta, Inc. | Chief Scientific Officer | Sale+OE | 6,400 | $39.25 | $251,228.74 | -4.3% | - | - |